Centene二季度业绩电话会重申上调2026年EPS指引但已被当日交易消化

Earnings Call Insights: Centene (CNC) Q2 2026
Management View
- Sarah London (CEO & Director) said, "Q2 adjusted diluted earnings per share of $2.51 exceeded our previous expectations" and added that Centene now expects "full year 2026 adjusted diluted earnings per share of greater than $4.80, up from our prior outlook of greater than $3.40 provided during our April update."
- London (CEO & Director) described Medicaid as steady but with higher-than-expected attrition, saying, "Medicaid results were in line with our expectations" and "We ended the quarter with just over 12 million members, a slightly larger step down in membership than anticipated." She added, "Rates remain a critical lever" and said "7/1 rates" were "better than expected," improving the 2026 composite rate forecast "from roughly 4.5% to roughly 5%."
- London (CEO & Director) highlighted Marketplace as a key driver of the guidance raise, stating, "we received favorable development on our final 2025 CMS risk adjustment reconciliation to the tune of $180 million in the quarter" and now expects Marketplace "pretax margin between 4.5% and 5%" for 2026.
- Andrew Asher (Executive VP & CFO) reported, "we reported very strong second quarter 2026 results, including $44.4 billion in premium and service revenue and adjusted diluted earnings per share of $2.51" and noted "approximately $0.50 of earnings in the quarter relating to settlements of 2025 items and amounts that we wouldn't expect to recur in 2027."
Outlook
- Management raised full-year earnings expectations, with London (CEO & Director) stating, "we now expect full year 2026 adjusted diluted earnings per share of greater than $4.80" and Asher (Executive VP & CFO) adding that the increase is "primarily driven by an improved Marketplace pretax margin of 4.5% to 5% and PDP margin of greater than 3%."
- Medicaid guidance incorporated higher membership attrition while holding back rate benefit, with Asher (Executive VP & CFO) saying, "we are holding the incremental 50 basis point benefit of the rate improvement to account for a little higher membership attrition in the back half of the year" and specifying, "we expect full year Medicaid membership to be down 8% to 9% compared to 12/31/25 versus our prior view of being down 6%."
- Compared with Q1, management’s Marketplace posture shifted from caution to confidence: in Q1, Asher (Executive VP & CFO) said Centene thought it "prudent to embed... a pretax margin for Marketplace around 3%," while in Q2, London (CEO & Director) said Marketplace is now expected to deliver a "pretax margin between 4.5% and 5%" after the June weekly report analysis.
Financial Results
- Asher (Executive VP & CFO) reported Q2 consolidated performance of "$44.4 billion in premium and service revenue" and "adjusted diluted earnings per share of $2.51," alongside a "consolidated HBR... 89.6%."
- Segment metrics included Asher (Executive VP & CFO) stating Medicaid HBR was "93.9%" with a full-year Medicaid HBR expectation "around 93.5%," while the Commercial segment "had... an HBR of 79.2%."
- Balance sheet and cash flow items included Asher (Executive VP & CFO) stating, "We ended the quarter with $715 million of cash available for general corporate use," and "Cash flow provided by operations was $8 billion year-to-date and $3.6 billion for Q2." He also said Centene repurchased "$260 million of senior notes" and ended with a "debt-to-cap ratio of 41.6%."
Q&A
- John Stansel, JPMorgan: asked about Medicaid attrition/acuity and OB3 pull-forward; Sarah London (CEO & Director) said attrition was "mostly... in the expansion population" and that "it's possible that, that will end up being some degree of pull forward," adding Centene is investing in "near real-time data exchange with states" to reduce disruption.
- Ann Hynes, Mizuho: asked if Medicaid margins can expand amid regulatory changes; London (CEO & Director) said the company cannot "hand wave it" but called OB3 "a more manageable effort than what we went through with redeterminations" and reiterated "our goal remains margin recovery for the Medicaid business even through the OB3 headwinds."
- Justin Lake, Wolfe: asked about Marketplace risk adjustment mechanics and 2026 assumptions; London (CEO & Director) said 2026 assumes "a meaningful receivable" and described Q2 utilization as "consistent with the higher acuity Silver membership... as confirmed by the Wakely data," while Asher (Executive VP & CFO) explained the $481 million disclosure includes "explicit margin... about $250 million" that "doesn't benefit the P&L relative to our prior guidance," leading to "$180 million better than our previous guidance."
- Andrew Mok, Barclays: asked about 2027 ACA pricing and market growth; London (CEO & Director) said pricing is "state-by-state" and that "our goal has been margin restoration," while adding the market should return to "normalized growth" but the company is "watching some of the lawsuits" affecting membership.
- Lance Wilkes, Bernstein: asked about ICHRA and Medicaid medical cost management; London (CEO & Director) said ICHRA is "roughly 50,000 members today" and "a 2.5x growth since last year," and also cited Medicaid progress in "ABA" and payment integrity work on "sepsis" coding.
Sentiment Analysis
- Analysts’ tone was slightly negative, with recurring pressure on Medicaid acuity/rates under OB3 and multi-year funding constraints, reflected in questions about whether "rates will catch up" (Kevin Fischbeck, BofA) and state funding changes (Scott Fidel, Goldman Sachs).
- Management’s tone was slightly positive in prepared remarks and more measured in Q&A: London (CEO & Director) emphasized "positive momentum" and being "confident," while also using qualifying language such as "it is certainly impactful" and "you cannot hand wave it" when addressing OB3.
- Versus Q1, management sounded more confident on Marketplace risk adjustment: Q1 described a "prudent posture" awaiting June Wakely data, while Q2 said the June weekly report "confirmed our hypothesis" and enabled an updated Marketplace margin outlook.
Quarter-over-quarter comparison
- Guidance shifted sharply upward: Q1 raised 2026 adjusted EPS to "greater than $3.40," while Q2 raised it to "greater than $4.80" and explicitly flagged "$0.50" of Q2 earnings as non-recurring into 2027.
- Marketplace moved from partial-risk-adjustment recognition and "3% pretax" framing in Q1 to a specific "4.5% to 5%" pretax margin outlook in Q2, supported by "$180 million" favorable 2025 risk adjustment reconciliation.
- Medicaid discussion moved from Q1 outperformance aided by "a flu season that was lighter" to Q2 focus on membership attrition, OB3 preparation, and a higher expected membership decline ("down 8% to 9%" vs. "down about 6%" previously).
Risks and Concerns
- Asher (Executive VP & CFO) cautioned on 2027 comparability, saying Q2 included earnings "we wouldn't expect to recur in 2027" and that this will matter when Centene provides a "bridge from 2026 to 2027 in a couple of quarters."
- Medicaid risk centered on attrition and acuity: London (CEO & Director) said guidance assumes "additional attrition will impact acuity" and that Centene set guidance "to account for that possibility in the second half of 2026."
- Marketplace risk included ongoing CMS eligibility verification and policy uncertainty: London (CEO & Director) said guidance accounts for membership impacts from "ongoing CMS program integrity efforts" and noted the company is monitoring legal and regulatory developments.
Final Takeaway
Centene’s Q2 narrative centered on a materially higher 2026 earnings outlook driven by Marketplace margin recovery and stronger PDP expectations, while management simultaneously framed Medicaid as operationally on plan but facing incremental membership attrition and OB3-related acuity uncertainty. Management emphasized that a portion of Q2 earnings was tied to 2025 settlements that are not expected to repeat in 2027, positioning upcoming quarters for more explicit 2026-to-2027 bridging and continued scrutiny on Medicaid rate/acuity alignment and Marketplace policy stability.
Read the full Earnings Call Transcript